Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $174,106 - $232,930
294 New
294 $228,000
Q2 2019

Jul 19, 2019

SELL
$110.79 - $129.32 $461,883 - $539,135
-4,169 Closed
0 $0
Q1 2019

Apr 17, 2019

BUY
$111.31 - $131.02 $464,051 - $546,222
4,169 New
4,169 $541,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dorchester Wealth Management CO Portfolio

Follow Dorchester Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorchester Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Dorchester Wealth Management CO with notifications on news.